AIIMS Delhi to start Covaxin trials on children in few days: Sources
The pediatric trials for Covaxin started in AIIMS Patna on Tuesday after Bharat Biotech`s COVID-19 vaccine received the Drugs Controller General of India (DCGI) nod to conduct clinical trials on children on May 11.
Jun 03, 2021, 17:40 PM IST
Waiting for Covaxin's approval by WHO, says Vietnam envoy
Speaking from Bengaluru to Zee Media, Pham Sanh Chau said, "Covaxin is not approved yet by WHO for emergency use, that is why we are waiting for this approval and then we will intensify the discussion.”
Jun 02, 2021, 15:49 PM IST
COVID Alert: Delhi left with 3,190 vaccine doses for 18-44 age group
Delhi is left with 3,190 COVID vaccine doses in its balance stock out of which 1,120 doses are of Covaxin and 2,070 of Covishield reserved for the age group 18-44 years.
May 31, 2021, 23:21 PM IST
India to import vaccines to speed up vaccination of entire population
Govt. of India, through NEGVAC, is doing regular interaction with national and international vaccine manufacturers like Pfizer, Moderna etc. to make the COVID-19 vaccines available in-country.
May 28, 2021, 23:31 PM IST
Key stakeholders come together ahead of WHO-Bharat Biotech meet on Covaxin approval
Bharat Biotech submitted application to the WHO for Emergency Use Listing (EUL) on April 19.
May 24, 2021, 21:24 PM IST
Bharat Biotech applies for WHO approval, pre-submission meeting soon
Hyderabad based Bharat Biotech has submitted an application to the WHO for Emergency Use Listing(EUL), becoming the 2nd made in India vaccine to apply at the global body for authorization.
May 24, 2021, 15:25 PM IST
COVID-19: Covaxin's paediatric trials may begin in June, Bharat Biotech expects WHO approval by end of Q3 or Q4
Dr Raches Ella also said that Bharat Biotech will be ramping up the manufacturing capacity of Covaxin to 700 million doses by the end of this year.
May 24, 2021, 07:25 AM IST
Exclusive: Bharat Biotech confident on COVID-19 vaccine production commitments, highlights need to ease out supply chains
Bharat Biotech said that if all goes well, it will complete the clinical trials for the 2-18 age group within the three months timeline.
Bharat Biotech to ramp up Covaxin production to additional 200 million doses per year
Bharat Biotech, the company which manufactures COVID-19 vaccine Covaxin, has decided to ramp up its production to manufacture additional 200 million doses per year.
May 20, 2021, 22:07 PM IST
Bharat Biotech's Covaxin effective against new COVID-19 variants, reveals study
A recent study has revealed that Bharat Biotech’s Covaxin produces neutralising titres against all new key variants of COVID-19 including the double mutant strain B.1.617 and B.1.1.7.
May 16, 2021, 12:26 PM IST
Maharashtra to raise its oxygen production capacity to 3,000 MT, says Ajit Pawar
Maharashtra Deputy Chief Minister Ajit Pawar on Friday (May 14) said the state government has set a target of producing 3,000 metric tonnes of oxygen per day to ensure that the state does not face a paucity of life-saving gas.
May 14, 2021, 16:42 PM IST
COVID-19 vaccine: Bharat Biotech ready to share formula of Covaxin with other manufacturers, says Centre
Amid a political war of words between the Centre and the Delhi government over the availability of sufficient vaccines to inoculate all adults in the national capital, the central government has said that leading drug maker Bharat Biotech is ready to share the formula of its anti-COVID vaccine COVAXIN with other manufacturers.
May 14, 2021, 09:01 AM IST
Government panel recommends 12-16 week gap between Covishield doses, no change for Covaxin
The recommendations were made by the National Technical Advisory Group on Immunisation (NTAGI) which suggested increasing the gap between two doses of Serum Institute of India`s COVISHIELD to 12-16 weeks.
May 13, 2021, 13:36 PM IST
50 employees of Bharat Biotech test COVID-19 positive; Joint MD's tweet sparks concern
The Hyderabad-based firm is supplying Covaxin to 18 states, including Andhra Pradesh, Haryana, Odisha, Assam, Jammu & Kashmir, Tamil Nadu, Bihar, Jharkhand and Delhi.
May 13, 2021, 12:43 PM IST
Bharat Biotech's Covaxin gets DCGI nod to conduct clinical trials on children above 2 years
The national drug regulator said that it has accepted the recommendation of the SEC “after careful examination” and accorded permission to Covaxin manufacturer Bharat Biotech.
May 13, 2021, 11:52 AM IST
Bharat Biotech to manufacture 2 crore doses of Covaxin at UP's Bulandshahr plant every month
As states face an acute shortage of COVID-19 vaccines, the central government on Wednesday (May 12, 2021) approved the proposal of Bharat Biotech to set up a new plant of Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) in Uttar Pradesh’s Bulandshahr.
May 13, 2021, 08:22 AM IST
COVID-19 vaccination for 18-44 age group halted in these states, know the reasons behind the decision
Due to the acute shortage of COVID-19 vaccines in the country, many states have temporarily suspended the vaccination drive for the people in the age group of 18 to 44 and have directed the available stock of doses for the above-45 age group.
May 13, 2021, 07:46 AM IST
Bharat Biotech's Covaxin gets approval for phase 2/3 trials on 2-18 year-olds
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech's application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.
May 12, 2021, 08:48 AM IST
Bharat Biotech slashes Covaxin rates for states to Rs 400
Bharat Biotech said in a statement, "We have made Covaxin available to state governments at a price of 400/ dose."
Apr 29, 2021, 21:53 PM IST
Bombay HC refuses to hear PIL seeking uniform rate of COVID-19 vaccines, tells petitioner to move SC
The Bombay High Court on Thursday refused to hear a PIL seeking a direction to the Serum Institute of India and the Bharat Biotech to sell their COVID-19 vaccines at a uniform rate of Rs 150 (plus GST) per dose.
Apr 29, 2021, 13:20 PM IST
